Former CFO Sandip Kapadia Files Intent to Sell Another $1.8 Million in Stock
HRMY sits 43% above its 52-week low of $25.52.
Summary
Former CFO Sandip Kapadia plans to sell $1.8 million in Harmony Biosciences stock, continuing a pattern of significant share dispositions since his departure.
Key Events · Ownership and Investor Activity · HRMY
-
Intent to Sell Additional Shares
Former CFO Sandip Kapadia filed a Form 144 to sell 50,000 shares of common stock, valued at approximately $1.8 million.
-
Continuation of Selling Pattern
This proposed sale follows previous dispositions by Mr. Kapadia, who has sold 132,606 shares totaling over $4.4 million in the last three months, indicating an ongoing liquidation of his stake.
-
Former Executive's Disposition
The filer, Sandip Kapadia, is a former officer of Harmony Biosciences, and his continued sales represent a significant reduction in holdings by a key former executive.
Analysis · HRMY · Life Sciences
Former CFO Sandip Kapadia has filed a Form 144 indicating his intent to sell an additional $1.8 million worth of Harmony Biosciences stock. This follows a series of sales totaling over $4.4 million in the past three months, signaling a continued liquidation of his holdings after his departure. This ongoing pattern of sales by a former key executive is a notable event for investors.
At the time of this filing, HRMY was trading at $36.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $25.52 to $40.87. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.